CYP4A22
Basic information
Region (hg38): 1:47137435-47149727
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (64 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CYP4A22 gene is commonly pathogenic or not. These statistics are base on transcript: NM_001010969.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 0 | |||||
| missense | 60 | 64 | ||||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 60 | 4 | 0 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| CYP4A22 | protein_coding | protein_coding | ENST00000371891 | 12 | 12307 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 1.42e-29 | 6.79e-7 | 125086 | 3 | 659 | 125748 | 0.00264 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | -1.17 | 352 | 295 | 1.19 | 0.0000159 | 3386 |
| Missense in Polyphen | 96 | 84.84 | 1.1315 | 1150 | ||
| Synonymous | 0.201 | 114 | 117 | 0.976 | 0.00000625 | 1020 |
| Loss of Function | -2.21 | 37 | 25.1 | 1.48 | 0.00000123 | 268 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.0183 | 0.0182 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.0104 | 0.0103 |
| Finnish | 0.00314 | 0.00315 |
| European (Non-Finnish) | 0.000438 | 0.000431 |
| Middle Eastern | 0.0104 | 0.0103 |
| South Asian | 0.000590 | 0.000588 |
| Other | 0.00116 | 0.00114 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the omega- and (omega-1)-hydroxylation of various fatty acids such as laurate and palmitate. Shows no activity towards arachidonic acid and prostaglandin A1. Lacks functional activity in the kidney and does not contribute to renal 20-hydroxyeicosatetraenoic acid (20-HETE) biosynthesis. {ECO:0000269|PubMed:10860550, ECO:0000269|PubMed:15611369}.;
- Pathway
- Fatty acid degradation - Homo sapiens (human);Vascular smooth muscle contraction - Homo sapiens (human);Oxidation by Cytochrome P450;Phase I - Functionalization of compounds;Metabolism of lipids;Synthesis of Leukotrienes (LT) and Eoxins (EX);Arachidonic acid metabolism;Fatty acids;Eicosanoids;Miscellaneous substrates;Cytochrome P450 - arranged by substrate type;Biological oxidations;Metabolism;Fatty acid metabolism;Arachidonic acid metabolism
(Consensus)
Recessive Scores
- pRec
- 0.182
Intolerance Scores
- loftool
- 0.871
- rvis_EVS
- 3.2
- rvis_percentile_EVS
- 99.35
Haploinsufficiency Scores
- pHI
- 0.281
- hipred
- N
- hipred_score
- 0.112
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0858
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | High | High | High |
| Primary Immunodeficiency | High | High | High |
| Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Cyp4a12b
- Phenotype
Gene ontology
- Biological process
- lipid hydroxylation;oxidation-reduction process;omega-hydroxylase P450 pathway
- Cellular component
- extracellular space;endoplasmic reticulum membrane;organelle membrane
- Molecular function
- iron ion binding;heme binding;arachidonic acid omega-hydroxylase activity;laurate hydroxylase activity;16-hydroxypalmitate dehydrogenase activity